Giuseppe Lombardi Selected Research

Giuseppe Lombardi Research Topics

Disease

40	Glioblastoma (Glioblastoma Multiforme) 12/2022 - 12/2010
35	Neoplasms (Cancer) 12/2022 - 08/2009
26	Glioma (Gliomas) 04/2022 - 10/2009
8	Disease Progression 08/2020 - 01/2011
7	Brain Neoplasms (Brain Tumor) 01/2022 - 09/2013
7	Pituitary Neoplasms (Pituitary Adenoma) 08/2020 - 01/2014
7	Erectile Dysfunction 04/2012 - 11/2007
6	Meningioma (Meningiomas) 01/2022 - 04/2014
6	Renal Cell Carcinoma (Grawitz Tumor) 09/2019 - 02/2010
5	Spinal Cord Injuries (Spinal Cord Injury) 07/2017 - 11/2007
4	Hepatocellular Carcinoma (Hepatoma) 12/2019 - 01/2011
4	Ovarian Neoplasms (Ovarian Cancer) 12/2016 - 08/2009
4	Multiple Sclerosis 04/2012 - 12/2008
3	Turcot syndrome 01/2021 - 01/2020
3	Edema (Dropsy) 01/2021 - 09/2013
3	Adenoma (Adenomas) 01/2020 - 01/2014
3	Headache (Headaches) 01/2014 - 11/2007
2	Astrocytoma (Pilocytic Astrocytoma) 04/2022 - 01/2022
2	Ependymoma 12/2021 - 01/2013
2	Prolactinoma (Prolactinomas) 08/2020 - 01/2019
2	Neutropenia 01/2019 - 06/2011
2	Hypertension (High Blood Pressure) 01/2018 - 01/2013
2	Carcinoma (Carcinomatosis) 02/2016 - 11/2004
2	Pleural Effusion (Pleural Effusions) 03/2012 - 08/2010
2	Meningitis 08/2011 - 01/2011
2	Amenorrhea 04/2011 - 09/2007
1	Fatigue 01/2022
1	Infections 01/2022
1	COVID-19 01/2022
1	Exanthema (Rash) 09/2021
1	Epilepsy (Aura) 09/2021
1	Oligodendroglioma 01/2021
1	Intracranial Hypertension 01/2021
1	Venous Thromboembolism 01/2021
1	Cerebral Hemorrhage 01/2021
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2020

Drug/Important Bio-Agent (IBA)

27	Temozolomide (Temodar)FDA LinkGeneric 05/2022 - 10/2009
15	Bevacizumab (Avastin)FDA Link 05/2019 - 02/2010
8	regorafenibIBA 04/2022 - 01/2019
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2013
6	Sorafenib (BAY 43-9006)FDA Link 07/2014 - 02/2010
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2018 - 12/2010
5	fotemustine (Muphoran)IBA 12/2018 - 01/2014
5	Phosphodiesterase 5 InhibitorsIBA 04/2012 - 02/2009
4	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 02/2022 - 05/2015
4	Immune Checkpoint InhibitorsIBA 01/2021 - 03/2019
4	Lomustine (CCNU)FDA Link 01/2021 - 01/2014
4	Hormones (Hormone)IBA 01/2019 - 09/2007
4	AcidsIBA 01/2017 - 06/2013
4	Cisplatin (Platino)FDA LinkGeneric 12/2016 - 10/2009
4	Tadalafil (Cialis)FDA Link 04/2012 - 11/2007
3	Pharmaceutical PreparationsIBA 09/2021 - 11/2007
3	depatuxizumab mafodotinIBA 06/2021 - 01/2020
3	pembrolizumabIBA 01/2021 - 01/2020
3	Proteins (Proteins, Gene)FDA Link 09/2020 - 01/2019
3	Adrenocorticotropic Hormone (ACTH)FDA Link 08/2020 - 01/2018
3	ErbB Receptors (EGF Receptor)IBA 01/2020 - 01/2012
3	Angiogenesis InhibitorsIBA 08/2017 - 01/2013
3	Carmustine (FIVB)FDA Link 01/2017 - 11/2011
3	liposomal doxorubicin (Doxil)FDA Link 06/2011 - 08/2009
3	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 06/2010 - 05/2009
2	Tyrosine Kinase InhibitorsIBA 02/2022 - 01/2012
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 01/2016
2	ABT-414IBA 01/2020 - 01/2020
2	Biological ProductsIBA 01/2020 - 05/2012
2	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2020 - 09/2007
2	Dopamine Agonists (Dopamine Agonist)IBA 01/2019 - 01/2014
2	ProlactinIBA 01/2019 - 01/2018
2	PlatinumIBA 12/2016 - 01/2013
2	alpha-hydroxyglutarateIBA 01/2016 - 05/2015
2	Gonadal Steroid Hormones (Sex Hormones)IBA 10/2014 - 04/2011
2	Testosterone (Sustanon)FDA Link 01/2014 - 09/2007
2	Sildenafil Citrate (Viagra)FDA Link 04/2012 - 12/2009
2	Paclitaxel (Taxol)FDA LinkGeneric 03/2012 - 06/2011
2	Monoclonal AntibodiesIBA 01/2012 - 12/2010
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 06/2011 - 08/2009
2	1-dodecylpyridoxal (PLD)IBA 06/2011 - 08/2009
2	Gemcitabine FDA Link 01/2011 - 07/2009
1	epidermal growth factor receptor VIIIIBA 12/2022
1	O-(6)-methylguanineIBA 05/2022
1	MethyltransferasesIBA 05/2022
1	NivolumabIBA 04/2022
1	VaccinesIBA 01/2022
1	TrabectedinIBA 01/2022
1	eslicarbazepineIBA 09/2021
1	AnticoagulantsIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2020

Therapy/Procedure

35	Therapeutics 04/2022 - 11/2007
19	Radiotherapy 04/2022 - 01/2013
15	Drug Therapy (Chemotherapy) 05/2022 - 06/2011
5	Chemoradiotherapy 05/2022 - 01/2019
3	Precision Medicine 12/2020 - 01/2020
2	Palliative Care (Palliative Therapy) 05/2022 - 03/2012
2	Aftercare (After-Treatment) 01/2022 - 01/2020
2	Immunotherapy 12/2021 - 07/2012
2	Combined Modality Therapy 09/2021 - 12/2020
2	Adjuvant Chemotherapy 08/2021 - 12/2020
2	Catheters 03/2012 - 08/2010
1	Ambulatory Care (Outpatient Care) 05/2022